ClearSky Medical Diagnostics
  • About Us
  • Products
    • LID-Monitor
    • PD-Monitor
    • CF-Monitor
    • ND-Monitor
  • Clinical Studies
  • News
  • Services
  • Pharma Trials
  • Contact
  • English
Select Page
LID-Monitor to also ‘manage bradykinesia’ // China study

LID-Monitor to also ‘manage bradykinesia’ // China study

by clearskymd | Jul 7, 2020 | Company News

We have launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor. Parkinson’s is the second most common neurodegenerative disorder and is characterised by bradykinesia – a slowness in carrying out movements....

Search

Recent Posts

  • ClearSky MD is a UK Life Sciences Innovator 2023
  • ClearSky presents at MEDICA 2022 in Germany
  • ClearSky heads to 2022 MDS International Congress in Madrid
  • SCOR Innovation Podcast: Interview with Professor Smith
  • ClearSky attends ADI 2022 London Conference

Recent Comments

    Archives

    • February 2023
    • December 2022
    • September 2022
    • June 2022
    • April 2022
    • March 2022
    • January 2022
    • December 2021
    • December 2020
    • November 2020
    • September 2020
    • July 2020
    • February 2020
    • October 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • January 2019
    • December 2018
    • September 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • May 2017

    Categories

    • Blog
    • Company News
    • Parkinson's
    • Facebook
    • Twitter
    © ClearSky Medical Diagnostics 2022 // Privacy Policy // Cookie Policy